NEMLC begins a GLP-1 medicines review to assess affordability and potential inclusion in the public health sector for diabetes and obesity
GLP-1 Medicines Review: South Africa Moves to Expand Access
Original Article by Tamar Kahn | Business Day | 1 December 2025
NEMLC begins a GLP-1 medicines review to assess affordability and potential inclusion in the public health sector for diabetes and obesity
More Posts
Thembisile Xulu Named New Health Director-General
Dr Thembisile Xulu is the new health Director-General, inheriting a strained department, healthcare-worker shortages and NHI litigation.
Read more...
Gauteng Nurse Shortage Deepens, Threatening NHI Rollout
Gauteng is losing 100 nurses a month and needs R5.7bn to fill a 16,000-post gap. This shortage now flagged as a key risk to the NHI rollout.
Read more...
Medical Schemes Should Be Allowed to Offer Low-Cost Benefit Options
Regulation, not demand, blocks affordable cover: medical schemes should be allowed to offer low-cost benefit options (LCBOs) now.
Read more...